US 11952408
HPV-specific binding molecules
granted A61KA61K2239/28A61K40/11
Quick answer
US patent 11952408 (HPV-specific binding molecules) held by Editas Medicine, Inc. expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Editas Medicine, Inc.
- Grant date
- Tue Apr 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 46
- CPC classes
- A61K, A61K2239/28, A61K40/11, A61K40/32, A61K40/42